Literature DB >> 8800804

Sandfly fever viruses in Italy.

L Nicoletti1, M G Ciufolini, P Verani.   

Abstract

Two serologically distinct agents, the sandfly fever Sicilian and the sandfly fever Naples viruses, were isolated by Sabin from blood samples taken during an Italian epidemic of febrile illness. Since then, several different viruses have been isolated from sandflies and/or humans in both the Old and New World. Toscana virus, a new virus closely antigenically related to sandfly fever Naples virus, was isolated in 1971 from the sandfly Phlebotomus perniciosus in Italy. Extensive studies on the importance of Toscana virus as a human pathogen demonstrated its association with acute neurologic diseases. A serosurvey for the presence of antibodies to sandfly fever Sicilian, sandfly fever Naples and Toscana viruses indicated that, as in other Mediterranean areas, both sandfly fever Sicilian and sandfly fever Naples viral infections decreased or disappeared after the 1940s in countries performing insecticide-spraying malaria eradication campaigns. In contrast, clinical cases of aseptic meningitis or meningoencephalitis caused by Toscana virus are observed annually in Central Italy during the summer. Toscana virus may be present in other Mediterranean countries where sandflies of the genus Phlebotomus are present.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8800804     DOI: 10.1007/978-3-7091-7482-1_5

Source DB:  PubMed          Journal:  Arch Virol Suppl        ISSN: 0939-1983


  8 in total

1.  Clinic-epidemiologic study of human infection by Granada virus, a new phlebovirus within the sandfly fever Naples serocomplex.

Authors:  José María Navarro-Marí; Cristina Gómez-Camarasa; Mercedes Pérez-Ruiz; Sara Sanbonmatsu-Gámez; Irene Pedrosa-Corral; María Jiménez-Valera
Journal:  Am J Trop Med Hyg       Date:  2013-02-18       Impact factor: 2.345

2.  Granada virus: a natural phlebovirus reassortant of the sandfly fever Naples serocomplex with low seroprevalence in humans.

Authors:  Ximena Collao; Gustavo Palacios; Fernando de Ory; Sara Sanbonmatsu; Mercedes Pérez-Ruiz; José María Navarro; Ricardo Molina; Stephen K Hutchison; W Ian Lipkin; Antonio Tenorio; María Paz Sánchez-Seco
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

3.  Performance of various commercial assays for the detection of Toscana virus antibodies.

Authors:  Koray Ergünay; Nadine Litzba; Modou Moustapha Lo; Sibel Aydoğan; Mehmet B Saygan; Dürdal Us; Manfred Weidmann; Matthias Niedrig
Journal:  Vector Borne Zoonotic Dis       Date:  2011-03-11       Impact factor: 2.133

Review 4.  A Mediterranean arbovirus: the Toscana virus.

Authors:  Marcello Valassina; Maria Grazia Cusi; Pier Egisto Valensin
Journal:  J Neurovirol       Date:  2003-12       Impact factor: 2.643

5.  Toscana virus in Spain.

Authors:  Sara Sanbonmatsu-Gámez; Mercedes Pérez-Ruiz; Ximena Collao; María Paz Sánchez-Seco; Francisco Morillas-Márquez; Manuel de la Rosa-Fraile; José Maria Navarro-Mari; Antonio Tenorio
Journal:  Emerg Infect Dis       Date:  2005-11       Impact factor: 6.883

6.  Serological and molecular detection of Toscana and other Phleboviruses in patients and sandflies in Tunisia.

Authors:  Ons Fezaa; Youmna M'ghirbi; Gianni Gori Savellini; Lamia Ammari; Nahed Hogga; Henda Triki; Maria Grazia Cusi; Ali Bouattour
Journal:  BMC Infect Dis       Date:  2014-11-15       Impact factor: 3.090

7.  Thirteen Years of Phleboviruses Circulation in Lombardy, a Northern Italy Region.

Authors:  Elena Percivalle; Irene Cassaniti; Mattia Calzolari; Davide Lelli; Fausto Baldanti
Journal:  Viruses       Date:  2021-01-29       Impact factor: 5.048

8.  Imported Chikungunya Infection, Italy.

Authors:  Anna Beltrame; Andrea Angheben; Zeno Bisoffi; Geraldo Monteiro; Stefania Marocco; Guido Calleri; Filippo Lipani; Federico Gobbi; Francesca Canta; Francesco Castelli; Maurizio Gulletta; Sara Bigoni; Veronica Del Punta; Tiziana Iacovazzi; Roberto Romi; Loredana Nicoletti; Maria Grazia Ciufolini; Giada Rorato; Camilla Negri; Pierluigi Viale
Journal:  Emerg Infect Dis       Date:  2007-08       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.